This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (189)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

United States: 1973 Through 1984

Benjamin M. Nkowane, MB, ChB, MPH; Steven G. F. Wassilak, MD; Walter A. Orenstein, MD; Kenneth J. Bart, MD, MPH; Lawrence B. Schonberger, MD, MPH; Alan R. Hinman, MD, MPH; Olen M. Kew, PhD

JAMA. 1987;257(10):1335-1340.

Abstract
From 1973 through 1984, there were 138 cases of paralytic poliomyelitis reported in the United States; 105 (76%) were vaccine associated. Of the 105 vaccine-associated cases, 35 occurred in recipients of oral polio vaccine (OPV), 50 in contacts to OPV recipients, 14 in immune deficient individuals, and six in individuals who had no history of receiving OPV or contact with recent OPV recipients. Thirty-three (94%) of the recipient cases, 41 (82%) of the contact cases, and five (36%) of the immune deficient cases were associated with the first dose of OPV. The overall frequency of vaccine-associated poliomyelitis was one case per 2.6 million doses distributed. However, the relative frequency of paralysis associated with the first dose in the OPV series was one case per 520 000 doses vs one case per 12.3 million subsequent doses. Vaccine-associated paralytic poliomyelitis is rare and the risks of OPV are small. The greatest likelihood of paralysis occurs in association with the first dose of OPV and that likelihood is reduced in subsequent doses more for recipients than for their contacts.

(JAMA 1987;257:1335-1340)

Author Affiliations
From the Division of Immunization, Center for Prevention Services (Drs Nkowane, Wassilak, Orenstein, Bart, and Hinman), and the Division of Viral Diseases, Center for Infectious Diseases (Drs Schonberger and Kew), Centers for Disease Control, Atlanta. Dr Nkowane is now with the Department of Community Medicine, School of Medicine, Lusaka, Zambia.

Footnotes
Reprint requests to Technical Information Services, Center for Prevention Services, Centers for Disease Control, Atlanta, GA 30333.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime
Arita et al.
J. Gen. Virol. 2009;90:1869-1879.
ABSTRACT | FULL TEXT  

Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity
Arita et al.
J. Gen. Virol. 2008;89:2518-2530.
ABSTRACT | FULL TEXT  

Use of a Multiple Restriction Fragment Length Polymorphism Method for Detecting Vaccine-Derived Polioviruses in Clinical Samples
Romanenkova et al.
J. Clin. Microbiol. 2006;44:4077-4084.
ABSTRACT | FULL TEXT  

Decision Analysis in Planning for a Polio Outbreak in the United States
Jenkins and Modlin
Pediatrics 2006;118:611-618.
ABSTRACT | FULL TEXT  

A Sabin 3-Derived Poliovirus Recombinant Contained a Sequence Homologous with Indigenous Human Enterovirus Species C in the Viral Polymerase Coding Region
Arita et al.
J. Virol. 2005;79:12650-12657.
ABSTRACT | FULL TEXT  

Vaccine Policy Changes and Epidemiology of Poliomyelitis in the United States
Alexander et al.
JAMA 2004;292:1696-1701.
ABSTRACT | FULL TEXT  

Poliomyelitis in the United States: The Final Chapter?
Modlin
JAMA 2004;292:1749-1751.
FULL TEXT  

Topical Review: Neurologic Complications of Immunization
Bale
J Child Neurol 2004;19:405-412.
ABSTRACT  

Excretion of Wild-Type and Vaccine-Derived Poliovirus in the Feces of Poliovirus Receptor-Transgenic Mice
Boot et al.
J. Virol. 2003;77:6541-6545.
ABSTRACT | FULL TEXT  

Neurovirulence of Type 1 Polioviruses Isolated from Sewage in Japan
Horie et al.
Appl. Environ. Microbiol. 2002;68:138-142.
ABSTRACT | FULL TEXT  

Evolution of the Sabin Strain of Type 3 Poliovirus in an Immunodeficient Patient during the Entire 637-Day Period of Virus Excretion
Martín et al.
J. Virol. 2000;74:3001-3010.
ABSTRACT | FULL TEXT  

Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report
Chitsike and van Furth
BMJ 1999;318:841-843.
ABSTRACT | FULL TEXT  

Polio vaccine: is it time for a change? • Commentary
Finn et al.
Arch. Dis. Child. 1998;78:571-574.
FULL TEXT  

Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host
Pirofski and Casadevall
Clin. Microbiol. Rev. 1998;11:1-26.
ABSTRACT | FULL TEXT  

Molecular Typing of Enteroviruses: Current Status and Future Requirements
Muir et al.
Clin. Microbiol. Rev. 1998;11:202-227.
ABSTRACT | FULL TEXT  

Inactivated Poliovirus Vaccine and Vaccine-Associated Paralytic Poliomyelitis
Brown
JAMA 1997;277:295-295.
ABSTRACT  

ANY QUESTIONS
Elliman
BMJ 1995;310:1044-1044.
FULL TEXT  

Adverse Events Associated With Childhood Vaccines Other Than Pertussis and Rubella: Summary of a Report From the Institute of Medicine
Stratton et al.
JAMA 1994;271:1602-1605.
ABSTRACT  

A Search for Persistent Measles, Mumps, and Rubella Vaccine Virus in Children With Human Immunodeficiency Virus Type 1 Infection
Frenkel et al.
Arch Pediatr Adolesc Med 1994;148:57-60.
ABSTRACT  

Vaccine-Associated Paralytic Poliomyelitis
Mermel et al.
NEJM 1993;329:810-811.
FULL TEXT  

The Susceptibility of Young Adult Americans to Vaccine-Preventable Infections: A National Serosurvey of US Army Recruits
Kelley et al.
JAMA 1991;266:2724-2729.
ABSTRACT  

Infections in HIV-infected Travelers: Risks and Prevention
Wilson et al.
ANN INTERN MED 1991;114:582-591.
ABSTRACT  

Vaccine-Associated Paralytic Poliomyelitis: Regional Case Series and Review
Querfurth and Swanson
Arch Neurol 1990;47:541-544.
ABSTRACT  

The Humoral Immune Response to Type 1 Oral Poliovirus Vaccine in Children Previously Immunized With Enhanced Potency Inactivated Poliovirus Vaccine or Live Oral Poliovirus Vaccine
Modlin et al.
Arch Pediatr Adolesc Med 1990;144:480-484.
ABSTRACT  

Health Advice for International Travel
HILL and PEARSON
ANN INTERN MED 1988;108:839-852.
ABSTRACT  

Poliomyelitis Prevention: Enhanced-Potency Inactivated Poliomyelitis Vaccine--Supplementary Statement
Arch Pediatr Adolesc Med 1988;142:139-140.
ABSTRACT  

Poliomyelitis Prevention: Enhanced-Potency Inactivated Poliomyelitis Vaccine--Supplementary Statement
JAMA 1988;259:345-346.
 

Polio Vaccination
Eggers and Mertens
JAMA 1987;258:322-323.
ABSTRACT